Accreditation Statement and Credit Designation

European Accreditation Council for Continuing Medical Education (UEMS/EACCME) 

An application was made to the UEMS-EACCME® for CME accreditation for this event.   

American Medical Association (AMA) 

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at https://www.ama-assn.org/education/ama-pra-credit-system/agreement-european-union-medical-specialties-uems  

Royal College of Physicians and Surgeons of Canada  

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. For more information, visit: https://www.royalcollege.ca/ca/en/cpd/royal-college-accredited-cpd-providers/international-accreditation-agreements.html  

Educational Objectives 

After attending this event, participants should be able to:

• Address individual needs in compliance with their Continuous Professional Development (CPD) plan
• Enhance dialogue with clinical investigators and basic scientists, as well as established investigators and young upcoming talents
• Assess the impact of COVID-19 on neurodegenerative diseases
• Evaluate the most recent research in treatment development and emerging therapeutic targets in Alzheimer’s disease
• Describe current developments in the treatment of Parkinson’s disease and related neurological disorders
• Evaluate the novel approaches to disease-modifying therapies for Parkinson’s disease
• Discuss common features of neurodegenerative diseases
• Evaluate the most recent advances in drug development and clinical trials in Neurogenerative diseases

Target Audience

The International Conference on Alzheimer’s and Parkinson’s Diseases is the global meeting place for international medical and scientific professionals worldwide engaged in the neurodegeneration field, from basic scientists to clinical investigators, and from established leaders to young upcoming talents. Because of the diverse, clinically focused educational offering, participants are able to tailor the curriculum to meet the needs of international clinicians of all levels of experience.

To Receive Your CME/CPD Certificate   

The CME/CPD certificate will be available after completing the online evaluation and credit-claiming procedure. The process takes about 5 minutes. We thank you for your feedback as it is an important part of CME/CPD accreditation and helps improve future educational offerings.

• Kindly note that the AD/PD 2025 online evaluation will be active on the last day of the meeting. You will then be able to access it and claim your CME/CPD certificate.

Disclosure and Resolution of Personal Conflicts of Interest  

In accordance with CME/CPD accreditation criteria and standards for commercial support to ensure balance, independence, objectivity, and scientific rigor, those in control of the educational content must disclose potential or actual conflicts of interest. Disclosure information is evaluated and conflicts of interest are resolved. Disclosure is made to participants prior to the activity. Participants will be asked on the evaluation to assess the objectivity and independence of the event.

• Disclosure information will be available here at least one week prior to the event.

Industry Support Disclosure  

This event is supported, in part, by funding from industry. All support is managed in strict accordance with CME/CPD accreditation criteria and standards for commercial support. Appropriate acknowledgement of all supporting organisations is made in the programme guide, on the event website, and with signage during the event.

• View a list of all industry supporters here. 
• View detailed programmes for all Industry Sessions here.

COMMITMENT TO THE HIGHEST STANDARDS IN CME/CPD